FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yoshimitsu Yamasaki

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Naoto Katakami; Shinji Kume; Hiroshi Maegawa; Hideaki Kaneto; Atsunori Kashiwagi; Takashi Uzu; Yoshimitsu Yamasaki; Iichiro Shimomura
Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.
Yoshimitsu Yamasaki; Hideaki Kaneto; Atsunori Kashiwagi; Naoto Katakami; Hideo Kusuoka; Kenichi Nakajima; Tsunehiko Nishimura
Improved Lipid Profiles are Associated with Reduced Incidence of Coronary Vascular Events in Asymptomatic Patients with Type 2 Diabetes and Impaired Myocardial Perfusion.
Chio Okuyama; Yoshimitsu Yamasaki; Kenichi Nakajima; Tsunehiko Nishimura
Prognostic value of myocardial perfusion imaging for cardiovascular events among asymptomatic Japanese patients with type 2 diabetes and mild renal dysfunction.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yoshimitsu Yamasaki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Naoto Katakami; Shinji Kume; Hiroshi Maegawa; Hideaki Kaneto; Atsunori Kashiwagi; Takashi Uzu; Yoshimitsu Yamasaki; Iichiro Shimomura
Association of myeloperoxidase G-463A gene polymorphism with diabetic nephropathy in Japanese type 2 diabetic subjects.
Endocrine journal 2013;60(4):457-71.
2013: Yoshimitsu Yamasaki; Hideaki Kaneto; Atsunori Kashiwagi; Naoto Katakami; Hideo Kusuoka; Kenichi Nakajima; Tsunehiko Nishimura
Improved Lipid Profiles are Associated with Reduced Incidence of Coronary Vascular Events in Asymptomatic Patients with Type 2 Diabetes and Impaired Myocardial Perfusion.
Journal of atherosclerosis and thrombosis 2013;20(4):330-5.
2013: Chio Okuyama; Yoshimitsu Yamasaki; Kenichi Nakajima; Tsunehiko Nishimura
Prognostic value of myocardial perfusion imaging for cardiovascular events among asymptomatic Japanese patients with type 2 diabetes and mild renal dysfunction.
Nuclear medicine communications 2013;34(4):328-32.
2013: Toyoko Naka; Yoshimitsu Yamasaki; Ayako Harada; Hideaki Kaneto; Naoto Katakami; Munehide Matsuhisa; Taka-Aki Matsuoka; Iichiro Shimomura
Association of serum copper levels and glycemic control in patients with type 2 diabetes.
Endocrine journal 2013;60(3):393-6.
2012: Ryohei Yamamoto; Yoshimitsu Yamasaki; Atsushi Yamauchi; Rieko Hayaishi-Okano; Enyu Imai; Naoto Katakami; Yasuyuki Nagasawa; Kentaro Ohtoshi; Hiromi Rakugi; Tatsuya Shoji; Yoshiharu Tsubakihara; Yoshitaka Isaka
A candidate gene approach to genetic contributors to the development of IgA nephropathy.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2012;27(3):1020-30.
2012: Naoto Katakami; Koichi Kawai; Ryuzo Kawamori; Norikazu Maeda; Munehide Matsuhisa; Taka-Aki Matsuoka; Keizo Ohno; Takeshi Osonoi; Ikki Shimizu; Tohru Funahashi; Kenichi Imamura; Fukashi Ishibashi; Hideaki Kaneto; Atsunori Kashiwagi; Mitsuyoshi Takahara; Yoshimitsu Yamasaki; Iichiro Shimomura
Adiponectin G276T gene polymorphism is associated with cardiovascular disease in Japanese patients with type 2 diabetes.
Atherosclerosis 2012;220(2):437-42.
2011: Naoto Katakami; K Kawai; Ryuzo Kawamori; Munehide Matsuhisa; Taka-aki Matsuoka; T Osonoi; Iichiro Shimomura; M Takahara; K Imamura; F Ishibashi; Tsutomu Kanda; Hideaki Kaneto; A Kashiwagi; Yoshimitsu Yamasaki
Aldose reductase C-106T gene polymorphism is associated with diabetic retinopathy in Japanese patients with type 2 diabetes.
Diabetes research and clinical practice 2011;92(3):e57-60.
2011: Naoto Katakami; Hideaki Kaneto; Munehide Matsuhisa; Iichiro Shimomura; Yoshimitsu Yamasaki
Effects of glimepiride and glibenclamide on carotid atherosclerosis in type 2 diabetic patients.
Diabetes research and clinical practice 2011;92(1):e20-2.
2011: Tetsuyuki Yasuda; Hideaki Kaneto; Naoto Katakami; Akio Kuroda; Taka-Aki Matsuoka; Yoshimitsu Yamasaki; Munehide Matsuhisa; Iichiro Shimomura
YKL-40, a new biomarker of endothelial dysfunction, is independently associated with albuminuria in type 2 diabetic patients.
Diabetes research and clinical practice 2011;91(2):e50-2.
2011: Naoto Katakami; Hideaki Kaneto; Takeshi Osonoi; Miyoko Saitou; Mitsuyoshi Takahara; Fumie Sakamoto; Kaoru Yamamoto; Tetsuyuki Yasuda; Taka-Aki Matsuoka; Munehide Matsuhisa; Yoshimitsu Yamasaki; Iichiro Shimomura
Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients.
Atherosclerosis 2011;214(2):442-7.
2010: Toshihiko Shiraiwa; Mitsuyoshi Takahara; Hideaki Kaneto; Takeshi Miyatsuka; Kaoru Yamamoto; Kazuhiro Yoshiuchi; Ken'ya Sakamoto; Taka-Aki Matsuoka; Munehide Matsuhisa; Yoshimitsu Yamasaki; Iichiro Shimomura
Efficacy of occasional self-monitoring of postprandial blood glucose levels in type 2 diabetic patients without insulin therapy.
Diabetes research and clinical practice 2010;90(3):e91-2.
2010: Yoshimitsu Yamasaki; Naoto Katakami; Shigetaka Furukado; Kazuo Kitagawa; Kazuyuki Nagatsuka; Atsunori Kashiwagi; Hiroyuki Daida; Ryuzo Kawamori; Kohei Kaku
Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity.
Journal of atherosclerosis and thrombosis 2010;17(11):1132-40.
2010: Naoto Katakami; Hideaki Kaneto; Taka-Aki Matsuoka; Mitsuyoshi Takahara; Kenichi Imamura; Fukashi Ishibashi; Tsutomu Kanda; Koichi Kawai; Takeshi Osonoi; Atsunori Kashiwagi; Ryuzo Kawamori; Munehide Matsuhisa; Iichiro Shimomura; Yoshimitsu Yamasaki
Accumulation of gene polymorphisms related to oxidative stress is associated with myocardial infarction in Japanese type 2 diabetic patients.
Atherosclerosis 2010;212(2):534-8.
2010: Naoto Katakami; Munehide Matsuhisa; Hideaki Kaneto; Taka-aki Matsuoka; Kenichi Imamura; Fukashi Ishibashi; Tsutomu Kanda; Koichi Kawai; Takeshi Osonoi; Atsunori Kashiwagi; Ryuzo Kawamori; Iichiro Shimomura; Yoshimitsu Yamasaki
Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for diabetic retinopathy in Japanese patients with type 2 diabetes.
Diabetes research and clinical practice 2010;89(1):e9-12.
2010: Naoto Katakami; Young Seol Kim; Ryuzo Kawamori; Yoshimitsu Yamasaki
The phosphodiesterase inhibitor cilostazol induces regression of carotid atherosclerosis in subjects with type 2 diabetes mellitus: principal results of the Diabetic Atherosclerosis Prevention by Cilostazol (DAPC) study: a randomized trial.
Circulation 2010;121(23):2584-91.
2010: Yoshimitsu Yamasaki; Naoto Katakami
[Recent advance in genetic marker for diabetic macroangiopathy].
Nihon rinsho. Japanese journal of clinical medicine 2010;68(5):803-8.
2010: Naoto Katakami; Mitsuyoshi Takahara; Hideaki Kaneto; Ikki Shimizu; Keizo Ohno; Fukashi Ishibashi; Takeshi Osonoi; Atsunori Kashiwagi; Ryuzo Kawamori; Iichiro Shimomura; Munehide Matsuhisa; Yoshimitsu Yamasaki
Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes.
Diabetes care 2010;33(2):390-5.
2009: Naoto Katakami; Munehide Matsuhisa; Hideaki Kaneto; Taka-aki Matsuoka; Ken'ya Sakamoto; Tetsuyuki Yasuda; Yutaka Umayahara; Keisuke Kosugi; Yoshimitsu Yamasaki
Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.
Atherosclerosis 2009;204(1):288-92.
2009: Naoto Katakami; Ken'ya Sakamoto; Hideaki Kaneto; Munehide Matsuhisa; I Shimizu; F Ishibashi; T Osonoi; A Kashiwagi; R Kawamori; Masatsugu Hori; Yoshimitsu Yamasaki
Combined effect of oxidative stress-related gene polymorphisms on atherosclerosis.
Biochemical and biophysical research communications 2009;379(4):861-5.
2009: Kazuhiro Yoshiuchi; Hideaki Kaneto; Taka-Aki Matsuoka; Ryuichi Kasami; Kenji Kohno; Takao Iwawaki; Yoshihisa Nakatani; Yoshimitsu Yamasaki; Iichiro Shimomura; Munehide Matsuhisa
Pioglitazone reduces ER stress in the liver: direct monitoring of in vivo ER stress using ER stress-activated indicator transgenic mice.
Endocrine journal 2009;56(9):1103-11.
2009: Ayako Tanaka; Hideaki Kaneto; Takeshi Miyatsuka; Kaoru Yamamoto; Kazuhiro Yoshiuchi; Yoshimitsu Yamasaki; Iichiro Shimomura; Taka-Aki Matsuoka; Munehide Matsuhisa
Role of copper ion in the pathogenesis of type 2 diabetes.
Endocrine journal 2009;56(5):699-706.
2008: Naoto Katakami; Munehide Matsuhisa; Hideaki Kaneto; Taka-Aki Matsuoka; Ken'ya Sakamoto; Tetsuyuki Yasuda; Yoshimitsu Yamasaki
Endogenous secretory RAGE but not soluble RAGE is associated with carotid atherosclerosis in type 1 diabetes patients.
Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease 2008;5(3):190-7.
2008: Ken Kato; Munehide Matsuhisa; Naotsugu Ichimaru; Shiro Takahara; Y Kojima; Kaoru Yamamoto; Toshihiko Shiraiwa; Akio Kuroda; Naoto Katakami; Ken'ya Sakamoto; Taka-aki Matsuoka; Hideaki Kaneto; Yoshimitsu Yamasaki; Masatsugu Hori
The impact of new-onset diabetes on arterial stiffness after renal transplantation.
Endocrine journal 2008;55(4):677-83.
2008: Satoshi Kawashima; Hideaki Kaneto; Ken'ya Sakamoto; Tetsuyuki Yasuda; Akio Kuroda; Toshihiko Shiraiwa; Kaoru Yamamoto; Ryuichi Kasami; Taka-Aki Matsuoka; Yoshimitsu Yamasaki; Munehide Matsuhisa
Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes.
Diabetes research and clinical practice 2008;81(2):e18-9.
2008: Naoto Katakami; Hideaki Kaneto; Yoshimitsu Yamasaki; Munehide Matsuhisa
Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy.
Diabetes research and clinical practice 2008;81(1):e4-7.
2008: Kazutomi Yoshiuchi; Munehide Matsuhisa; Naoto Katakami; Yoshihisa Nakatani; Kenya Sakamoto; Takaaki Matsuoka; Yutaka Umayahara; Keisuke Kosugi; Hideaki Kaneto; Yoshimitsu Yamasaki; Masatsugu Hori
Glycated albumin is a better indicator for glucose excursion than glycated hemoglobin in type 1 and type 2 diabetes.
Endocrine journal 2008;55(3):503-7.
2008: Hideaki Kaneto; Takeshi Miyatsuka; Dan Kawamori; Kaoru Yamamoto; Ken Kato; Toshihiko Shiraiwa; Naoto Katakami; Yoshimitsu Yamasaki; Munehide Matsuhisa; Taka-Aki Matsuoka
PDX-1 and MafA play a crucial role in pancreatic beta-cell differentiation and maintenance of mature beta-cell function.
Endocrine journal 2008;55(2):235-52.
2008: Naoto Katakami; Hideaki Kaneto; Munehide Matsuhisa; Yutaka Umayahara; Keisuke Kosugi; Yoshimitsu Yamasaki
Clustering of several cardiovascular risk factors affects tissue characteristics of the carotid artery.
Atherosclerosis 2008;198(1):208-13.
2008: Satoshi Kawashima; Hideaki Kaneto; Ken'ya Sakamoto; Ikuko Honsho; Tetsuyuki Yasuda; Akio Kuroda; Toshihiko Shiraiwa; Ryuichi Kasami; Taka-aki Matsuoka; Yoshimitsu Yamasaki; Munehide Matsuhisa
Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment.
Diabetes care 2008;31(3):e11.
2008: Kazuhiro Yoshiuchi; Hideaki Kaneto; Taka-Aki Matsuoka; Kenji Kohno; Takao Iwawaki; Yoshihisa Nakatani; Yoshimitsu Yamasaki; Masatsugu Hori; Munehide Matsuhisa
Direct monitoring of in vivo ER stress during the development of insulin resistance with ER stress-activated indicator transgenic mice.
Biochemical and biophysical research communications 2008;366(2):545-50.
2008: Tomomi Fujisawa; Hiroshi Ikegami; Soji Kasayama; Munehide Matsuhisa; Yoshimitsu Yamasaki; Jun-ichiro Miyagawa; Tohru Funahashi; Iichiro Shimomura
Age-dependent difference in factors affecting choice of system for self-monitoring of blood glucose.
Diabetes research and clinical practice 2008;79(1):103-7.
2007: Tetsuyuki Yasuda; Munehide Matsuhisa; Noritaka Fujiki; Fumie Sakamoto; Mayumi Tsuji; Noriko Fujisawa; Masato Kimura; Rieko Ishibashi; Hideaki Kaneto; Yoshimitsu Yamasaki; Takao Watarai; Eiichi Imano
Is central obesity a good predictor of carotid atherosclerosis in Japanese type 2 diabetes with metabolic syndrome?
Endocrine journal 2007;54(5):695-702.
2007: Kaoru Yamamoto; Takeshi Miyatsuka; Ayako Tanaka; Shuichi Toyoda; Ken Kato; Toshihiko Shiraiwa; Yoshio Fujitani; Yoshimitsu Yamasaki; Masatsugu Hori; Munehide Matsuhisa; Taka-aki Matsuoka; Hideaki Kaneto
Tissue-specific deletion of c-Jun in the pancreas has limited effects on pancreas formation.
Biochemical and biophysical research communications 2007;363(4):908-14.
2007: Hideaki Kaneto; Taka-Aki Matsuoka; Naoto Katakami; Dan Kawamori; Takeshi Miyatsuka; Kazuhiro Yoshiuchi; Tetsuyuki Yasuda; Ken'ya Sakamoto; Yoshimitsu Yamasaki; Munehide Matsuhisa
Oxidative stress and the JNK pathway are involved in the development of type 1 and type 2 diabetes.
Current molecular medicine 2007;7(7):674-86.
2007: Taka-aki Matsuoka; Hideaki Kaneto; Roland Stein; Takeshi Miyatsuka; Dan Kawamori; Eva Henderson; Itaru Kojima; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki
MafA regulates expression of genes important to islet beta-cell function.
Molecular endocrinology (Baltimore, Md.) 2007;21(11):2764-74.
2007: Toshihiko Shiraiwa; Hideaki Kaneto; Takeshi Miyatsuka; Ken Kato; Kaoru Yamamoto; Ayaha Kawashima; Yoshitaka Kajimoto; Taka-Aki Matsuoka; Munehide Matsuhisa; Yoshimitsu Yamasaki; Yoshio Fujitani
Establishment of a non-invasive mouse reporter model for monitoring in vivo pdx-1 promoter activity.
Biochemical and biophysical research communications 2007;361(3):739-44.
2007: Munehide Matsuhisa; Yoshimitsu Yamasaki; Masanori Emoto; Michio Shimabukuro; Shinichiro Ueda; Tohru Funahashi; Yuji Matsuzawa
A novel index of insulin resistance determined from the homeostasis model assessment index and adiponectin levels in Japanese subjects.
Diabetes research and clinical practice 2007;77(1):151-4.
2007: Hideaki Kaneto; Naoto Katakami; Dan Kawamori; Takeshi Miyatsuka; Ken'ya Sakamoto; Taka-Aki Matsuoka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Involvement of oxidative stress in the pathogenesis of diabetes.
Antioxidants & redox signaling 2007;9(3):355-66.
2007: Naoto Katakami; Hideaki Kaneto; Munehide Matsuhisa; Kazuhiro Yoshiuchi; Ken Kato; Kaoru Yamamoto; Yutaka Umayahara; Keisuke Kosugi; Masatsugu Hori; Yoshimitsu Yamasaki
Serum interleukin-18 levels are increased and closely associated with various soluble adhesion molecule levels in type 1 diabetic patients.
Diabetes care 2007;30(1):159-61.
2006: Yoshimitsu Yamasaki; Naoto Katakami
[Measurement of IMT by echotomography].
Nihon rinsho. Japanese journal of clinical medicine 2006;64 Suppl 9():521-5.
2006: Yumiko Nakamura; Hideaki Kaneto; Takeshi Miyatsuka; Taka-aki Matsuoka; Munehide Matsuhisa; Koichi Node; Masatsugu Hori; Yoshimitsu Yamasaki
Marked increase of insulin gene transcription by suppression of the Rho/Rho-kinase pathway.
Biochemical and biophysical research communications 2006;350(1):68-73.
2006: Yoshimitsu Yamasaki; Naoto Katakami
[Strategy for order-made treatment of diabetic macroangiopathy].
Nihon rinsho. Japanese journal of clinical medicine 2006;64(11):2148-52.
2006: Yoshimitsu Yamasaki; Naoto Katakami; Ken'ya Sakamoto; Hideaki Kaneto; Munehide Matsuhisa; Hiroshi Sato; Masatsugu Hori; Masakazu Haneda; Atsunori Kashiwagi; Yasushi Tanaka; Ryuzo Kawamori; Shin-Ichi Kuno
Combination of multiple genetic risk factors is synergistically associated with carotid atherosclerosis in Japanese subjects with type 2 diabetes.
Diabetes care 2006;29(11):2445-51.
2006: Naoto Katakami; Hideaki Kaneto; Munehide Matsuhisa; Takeshi Miyatsuka; Ken'ya Sakamoto; Dan Kawamori; Kazuhiro Yoshiuchi; Yusuke Nakamura; Ken Kato; Kazuhiro Yamamoto; Keisuke Kosugi; Masatsugu Hori; Yoshimitsu Yamasaki
Association of soluble CD40 ligand with carotid atherosclerosis in Japanese type 1 diabetic patients.
Diabetologia 2006;49(7):1670-6.
2006: Takeshi Miyatsuka; Hideaki Kaneto; Toshihiko Shiraiwa; Taka-aki Matsuoka; Kaoru Yamamoto; Ken Kato; Yumiko Nakamura; Shizuo Akira; Kiyoshi Takeda; Yoshitaka Kajimoto; Yoshimitsu Yamasaki; Eric P Sandgren; Yoshiya Kawaguchi; Christopher V E Wright; Yoshio Fujitani
Persistent expression of PDX-1 in the pancreas causes acinar-to-ductal metaplasia through Stat3 activation.
Genes & development 2006;20(11):1435-40.
2006: Shin-Ichi Gorogawa; Osamu Iida; M Ikeda; Takao Watarai; M Kubota; Shinsuke Nanto; Hideaki Kaneto; Yoshimitsu Yamasaki
Characteristics of peripheral arterial disease in Japanese type 2 diabetic patients.
Diabetologia 2006;49(6):1449-51.
2006: Yoji Hazama; Munehide Matsuhisa; Kentaro Ohtoshi; Shin-Ichi Gorogawa; Ken Kato; Dan Kawamori; Kazuhiro Yoshiuchi; Yumiko Nakamura; Toshihiko Shiraiwa; Hideaki Kaneto; Yoshimitsu Yamasaki; Masatsugu Hori
Beneficial effects of nateglinide on insulin resistance in type 2 diabetes.
Diabetes research and clinical practice 2006;71(3):251-5.
2006: Yoshihisa Nakatani; Hideaki Kaneto; Masahiro Hatazaki; Kazuhiro Yoshiuchi; Dan Kawamori; Ken'ya Sakamoto; Taka-aki Matsuoka; Satoshi Ogawa; Yoshimitsu Yamasaki; Munehide Matsuhisa
Increased stress protein ORP150 autoantibody production in Type 1 diabetic patients.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(2):216-9.
2006: Dan Kawamori; Hideaki Kaneto; Yoshihisa Nakatani; Taka-Aki Matsuoka; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki
The forkhead transcription factor Foxo1 bridges the JNK pathway and the transcription factor PDX-1 through its intracellular translocation.
The Journal of biological chemistry 2006;281(2):1091-8.
2006: Yoshimitsu Yamasaki; Young Seol Kim; Ryuzo Kawamori
Rationale and protocol of a trial for prevention of diabetic atherosclerosis by using antiplatelet drugs: study of Diabetic Atherosclerosis Prevention by Cilostazol (DAPC study).
Cardiovascular diabetology 2006;5():16.
2006: Hideaki Kaneto; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Taka-aki Matsuoka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.
The international journal of biochemistry & cell biology 2006;38(5-6):782-93.
2005: Naoto Katakami; Ken'ya Sakamoto; Hideaki Kaneto; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki; Keisuke Kosugi; Hidehiko Waki
Lipid-lowering with atorvastatin improves tissue characteristics of carotid plaque.
Atherosclerosis 2005;183(2):369-71.
2005: Hideaki Kaneto; Dan Kawamori; Taka-aki Matsuoka; Yoshitaka Kajimoto; Yoshimitsu Yamasaki
Oxidative stress and pancreatic beta-cell dysfunction.
American journal of therapeutics 2005;12(6):529-33.
2005: Toshihiko Shiraiwa; Hideaki Kaneto; Takeshi Miyatsuka; Ken Kato; Kaoru Yamamoto; Ayaha Kawashima; Tsutomu Kanda; Masaaki Suzuki; Eiichi Imano; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki
Postprandial hyperglycemia is a better predictor of the progression of diabetic retinopathy than HbA1c in Japanese type 2 diabetic patients.
Diabetes care 2005;28(11):2806-7.
2005: Naoto Katakami; Munehide Matsuhisa; Hideaki Kaneto; Taka-Aki Matsuoka; Ken'ya Sakamoto; Yoshihisa Nakatani; Kentaro Ohtoshi; Rieko Hayaishi-Okano; Keisuke Kosugi; Masatsugu Hori; Yoshimitsu Yamasaki
Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications.
Diabetes care 2005;28(11):2716-21.
2005: Toshihiko Shiraiwa; Hideaki Kaneto; Takeshi Miyatsuka; Ken Kato; Kaoru Yamamoto; Ayaha Kawashima; Tsutomu Kanda; Masaaki Suzuki; Eiichi Imano; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki
Post-prandial hyperglycemia is an important predictor of the incidence of diabetic microangiopathy in Japanese type 2 diabetic patients.
Biochemical and biophysical research communications 2005;336(1):339-45.
2005: Yoshimitsu Yamasaki
[Postprandial hyperglycemia as a risk factor of atherosclerosis].
Nihon rinsho. Japanese journal of clinical medicine 2005;63(10):1851-6.
2005: Masahiro Hatazaki; Munehide Matsuhisa; Yoshihisa Nakatani; Kazuhiro Yoshiuchi; Akio Kuroda; Yoji Hazama; Hideaki Kaneto; Yoshimitsu Yamasaki; Masatsugu Hori
Hepatic insulin resistance induced by chronic hindlimb ischemia.
Diabetes research and clinical practice 2005;69(3):209-15.
2005: Hideaki Kaneto; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Taka-aki Matsuoka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance.
The international journal of biochemistry & cell biology 2005;37(8):1595-608.
2005: Shin-Ichi Gorogawa; Hideaki Kaneto; Munehide Matsuhisa; Kentaro Ohtoshi; Dan Kawamori; Yoji Hazama; Kazuhiro Yoshiuchi; Yoshimitsu Yamasaki
Possible novel index determined by the glucose clamp test for selection of a suitable therapy for each type 2 diabetic patient.
Diabetes research and clinical practice 2005;69(1):1-4.
2005: Yoshimitsu Yamasaki
[Prognosis of diabetic microangiopathy].
Nihon rinsho. Japanese journal of clinical medicine 2005;63 Suppl 6():32-6.
2005: Hideaki Kaneto; Taka-Aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Takeshi Miyatsuka; Munehide Matsuhisa; Yoshimitsu Yamasaki
Oxidative stress, ER stress, and the JNK pathway in type 2 diabetes.
Journal of molecular medicine (Berlin, Germany) 2005;83(6):429-39.
2005: Kentaro Ohtoshi; Hideaki Kaneto; Koichi Node; Yumiko Nakamura; Toshihiko Shiraiwa; Munehide Matsuhisa; Yoshimitsu Yamasaki
Association of soluble epoxide hydrolase gene polymorphism with insulin resistance in type 2 diabetic patients.
Biochemical and biophysical research communications 2005;331(1):347-50.
2005: Hideaki Kaneto; Taka-aki Matsuoka; Yoshihisa Nakatani; Takeshi Miyatsuka; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki
A crucial role of MafA as a novel therapeutic target for diabetes.
The Journal of biological chemistry 2005;280(15):15047-52.
2005: Hideaki Kaneto; Yoshihisa Nakatani; Takeshi Miyatsuka; Taka-aki Matsuoka; Munehide Matsuhisa; Masatsugu Hori; Yoshimitsu Yamasaki
PDX-1/VP16 fusion protein, together with NeuroD or Ngn3, markedly induces insulin gene transcription and ameliorates glucose tolerance.
Diabetes 2005;54(4):1009-22.
2005: Kentaro Ozawa; Mayuki Miyazaki; Munehide Matsuhisa; Katsura Takano; Yoshihisa Nakatani; Masahiro Hatazaki; Takashi Tamatani; Kazuya Yamagata; Jun-Ichiro Miyagawa; Yasuko Kitao; Osamu Hori; Yoshimitsu Yamasaki; Satoshi Ogawa
The endoplasmic reticulum chaperone improves insulin resistance in type 2 diabetes.
Diabetes 2005;54(3):657-63.
2005: Yoshimitsu Yamasaki; Naoto Katakami; Rieko Hayaishi-Okano; Munehide Matsuhisa; Yoshitaka Kajimoto; Keisuke Kosugi; Mitue Hatano; Masatsugu Hori
alpha-Glucosidase inhibitor reduces the progression of carotid intima-media thickness.
Diabetes research and clinical practice 2005;67(3):204-10.
2005: Hideaki Kaneto; Taka-Aki Matsuoka; Yoshihisa Nakatani; Dan Kawamori; Munehide Matsuhisa; Yoshimitsu Yamasaki
Oxidative stress and the JNK pathway in diabetes.
Current diabetes reviews 2005;1(1):65-72.
2005: Yoshihisa Nakatani; Hideaki Kaneto; Dan Kawamori; Kazuhiro Yoshiuchi; Masahiro Hatazaki; Taka-aki Matsuoka; Kentaro Ozawa; Satoshi Ogawa; Masatsugu Hori; Yoshimitsu Yamasaki; Munehide Matsuhisa
Involvement of endoplasmic reticulum stress in insulin resistance and diabetes.
The Journal of biological chemistry 2005;280(1):847-51.
2004: Naoto Katakami; Hideaki Kaneto; Hiroyuki Hao; Yutaka Umayahara; Yoshio Fujitani; Ken'ya Sakamoto; Shin-Ichi Gorogawa; Tetsuyuki Yasuda; Dan Kawamori; Yoshitaka Kajimoto; Munehide Matsuhisa; Chikao Yutani; Masatsugu Hori; Yoshimitsu Yamasaki
Role of pim-1 in smooth muscle cell proliferation.
The Journal of biological chemistry 2004;279(52):54742-9.
2004: Naoto Katakami; Yoshimitsu Yamasaki; Rieko Hayaishi-Okano; Kentaro Ohtoshi; Hideaki Kaneto; Munehide Matsuhisa; Keisuke Kosugi; Masatsugu Hori
Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.
Diabetologia 2004;47(11):1906-13.
2004: Itsuro Nakahara; Munehide Matsuhisa; Yuichi Shiba; Akio Kuroda; Yoshihisa Nakatani; Masahiro Hatazaki; Yoshitaka Kajimoto; Minoru Kubota; Yoshimitsu Yamasaki; Masatsugu Hori
Acute elevation of free fatty acids impairs hepatic glucose uptake in conscious rats.
Diabetes research and clinical practice 2004;66(2):109-18.
2004: Yoshihisa Nakatani; Hideaki Kaneto; Dan Kawamori; Masahiro Hatazaki; Takeshi Miyatsuka; Taka-Aki Matsuoka; Yoshitaka Kajimoto; Munehide Matsuhisa; Yoshimitsu Yamasaki; Masatsugu Hori
Modulation of the JNK pathway in liver affects insulin resistance status.
The Journal of biological chemistry 2004;279(44):45803-9.
2004: Hideaki Kaneto; Yoshihisa Nakatani; Takeshi Miyatsuka; Dan Kawamori; Taka-aki Matsuoka; Munehide Matsuhisa; Yoshitaka Kajimoto; Hidenori Ichijo; Yoshimitsu Yamasaki; Masatsugu Hori
Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide.
Nature medicine 2004;10(10):1128-32.
2004: Shin-Ichi Gorogawa; Yoshio Fujitani; Hideaki Kaneto; Yoji Hazama; Hirotaka Watada; Yasuhide Miyamoto; Kiyoshi Takeda; Shizuo Akira; Mark Magnuson; Yoshimitsu Yamasaki; Yoshitaka Kajimoto; Masatsugu Hori
Insulin secretory defects and impaired islet architecture in pancreatic beta-cell-specific STAT3 knockout mice.
Biochemical and biophysical research communications 2004;319(4):1159-70.
2004: Naoto Katakami; Yoshimitsu Yamasaki; Keisuke Kosugi
[Integrated backscatter for diagnosis of arteriosclerosis].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 3():283-6.
2004: Naoto Katakami; Yoshimitsu Yamasaki; Keisuke Kosugi; Hidehiko Waki; Munehide Matsuhisa; Yoshitaka Kajimoto; Tohru Masuyama; Masatsugu Hori
Tissue characterization identifies subjects with high risk of cardiovascular diseases.
Diabetes research and clinical practice 2004;63(2):93-102.
2004: Yoshimitsu Yamasaki
[Evaluation of carotid artery lesion by echography].
Nihon rinsho. Japanese journal of clinical medicine 2004;62(1):87-96.
2003: Dan Kawamori; Yoshitaka Kajimoto; Hideaki Kaneto; Yutaka Umayahara; Yoshio Fujitani; Takeshi Miyatsuka; Hirotaka Watada; Ingo B Leibiger; Yoshimitsu Yamasaki; Masatsugu Hori
Oxidative stress induces nucleo-cytoplasmic translocation of pancreatic transcription factor PDX-1 through activation of c-Jun NH(2)-terminal kinase.
Diabetes 2003;52(12):2896-904.
2003: Takeshi Miyatsuka; Hideaki Kaneto; Yoshitaka Kajimoto; Shun Hirota; Y Arakawa; Yoshio Fujitani; Yutaka Umayahara; Hirotaka Watada; Yoshimitsu Yamasaki; Mark Magnuson; J i Miyazaki; Masatsugu Hori
Ectopically expressed PDX-1 in liver initiates endocrine and exocrine pancreas differentiation but causes dysmorphogenesis.
Biochemical and biophysical research communications 2003;310(3):1017-25.
2003: Akio Kuroda; Yoshimitsu Yamasaki; Munehide Matsuhisa; Minoru Kubota; Itsuro Nakahara; Yoshihisa Nakatani; Ayumu Hoshi; Shin-Ichi Gorogawa; Yutaka Umayahara; Yasushi Itakura; Tsutomu Nakagawa; Mutsuo Taiji; Yoshitaka Kajimoto; Masatsugu Hori
Brain-derived neurotrophic factor ameliorates hepatic insulin resistance in Zucker fatty rats.
Metabolism: clinical and experimental 2003;52(2):203-8.
2003: Rieko Hayaishi-Okano; Yoshimitsu Yamasaki; Yoshitaka Kajimoto; Ken'ya Sakamoto; Kentaro Ohtoshi; Naoto Katakami; Dan Kawamori; Takeshi Miyatsuka; Masahiro Hatazaki; Yoji Hazama; Masatsugu Hori
Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes.
Diabetes care 2003;26(2):458-63.
2002: Kentaro Ohtoshi; Yoshimitsu Yamasaki; Shin-Ichi Gorogawa; Rieko Hayaishi-Okano; Koichi Node; Munehide Matsuhisa; Yoshitaka Kajimoto; Masatsugu Hori
Association of (-)786T-C mutation of endothelial nitric oxide synthase gene with insulin resistance.
Diabetologia 2002;45(11):1594-601.
2002: Yoshimitsu Yamasaki; Takeshi Miyatsuka
[Insulin absorption from mucosal membrane].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 9():528-33.
2002: Yoshimitsu Yamasaki; Akio Kuroda
[Adverse effect of biguanides].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 9():389-92.
2002: Yoshimitsu Yamasaki; Kentaro Ohtoshi
[Esophageal echo-tomography].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 8():682-7.
2002: Yoshimitsu Yamasaki; Naoto Katakami
[Clinical usefulness of echo-tomography of carotid artery].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 8():670-5.
2002: Yoshimitsu Yamasaki; Dan Kawamori
[Aortic pulse wave velocity].
Nihon rinsho. Japanese journal of clinical medicine 2002;60 Suppl 8():631-5.
2002: Rieko Hayaishi-Okano; Yoshimitsu Yamasaki; Naoto Katakami; Kentaro Ohtoshi; Shin-Ichi Gorogawa; Akio Kuroda; Munehide Matsuhisa; Keisuke Kosugi; Norikiyo Nishikawa; Yoshitaka Kajimoto; Masatsugu Hori
Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes.
Diabetes care 2002;25(8):1432-8.
2002: Shigeru Yoshida; Yoshitaka Kajimoto; Tetsuyuki Yasuda; Hirotaka Watada; Yoshio Fujitani; Hiroshi Kosaka; Takahiro Gotow; Takeshi Miyatsuka; Yutaka Umayahara; Yoshimitsu Yamasaki; Masatsugu Hori
PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells.
Diabetes 2002;51(8):2505-13.
2002: Shin-Ichi Gorogawa; Yoshitaka Kajimoto; Yutaka Umayahara; Hideaki Kaneto; Hirotaka Watada; Akio Kuroda; Dan Kawamori; Tetsuyuki Yasuda; Munehide Matsuhisa; Yoshimitsu Yamasaki; Masatsugu Hori
Probucol preserves pancreatic beta-cell function through reduction of oxidative stress in type 2 diabetes.
Diabetes research and clinical practice 2002;57(1):1-10.
2002: Yutaka Umayahara; Yoshitaka Kajimoto; Yoshio Fujitani; Shin-Ichi Gorogawa; Tetsuyuki Yasuda; Akio Kuroda; Kentaro Ohtoshi; Shigeru Yoshida; Dan Kawamori; Yoshimitsu Yamasaki; Masatsugu Hori
Protein kinase C-dependent, CCAAT/enhancer-binding protein beta-mediated expression of insulin-like growth factor I gene.
The Journal of biological chemistry 2002;277(18):15261-70.
2002: T Shinoda-Tagawa; Yoshimitsu Yamasaki; S Yoshida; Yoshitaka Kajimoto; T Tsujino; N Hakui; M Matsumoto; Masatsugu Hori
A phosphodiesterase inhibitor, cilostazol, prevents the onset of silent brain infarction in Japanese subjects with Type II diabetes.
Diabetologia 2002;45(2):188-94.
2002: Rieko Hayaishi-Okano; Yoshimitsu Yamasaki; Kentaro Ohtoshi; Tetsuyuki Yasuda; Naoto Katakami; Tsutomu Hirano; Gen Yoshino; Yoshitaka Kajimoto; Masatsugu Hori
NAD (P) H oxidase p22 phox C242T polymorphism affects LDL particle size and insulin resistance in Japanese subjects.
Journal of atherosclerosis and thrombosis 2002;9(4):200-5.
2002: Tetsuyuki Yasuda; Yoshitaka Kajimoto; Yoshio Fujitani; Hirotaka Watada; Yamamoto Shuji; Takao Watarai; Yutaka Umayahara; Munehide Matsuhisa; Shin-Ichi Gorogawa; Yasuaki Kuwayama; Yasuo Tano; Yoshimitsu Yamasaki; Masatsugu Hori
PAX6 mutation as a genetic factor common to aniridia and glucose intolerance.
Diabetes 2002;51(1):224-30.
2001: Yoshimitsu Yamasaki; M Shichiri; M Nomura; T Yagi
[Trans mucosal insulin delivery].
Nihon rinsho. Japanese journal of clinical medicine 2001;59(11):2134-9.
2001: Eiichi Imano; Takeshi Miyatsuka; M Motomura; Tsutomu Kanda; Munehide Matsuhisa; Y Kajimoto; Yoshimitsu Yamasaki; Masatsugu Hori
Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria.
Diabetes research and clinical practice 2001;52(3):185-91.
2000: Yoshimitsu Yamasaki; M Kodama; Hitoshi Nishizawa; Ken'ya Sakamoto; Munehide Matsuhisa; Yoshitaka Kajimoto; Keisuke Kosugi; Yoshiomi Shimizu; Ryuzo Kawamori; Masatsugu Hori
Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease.
Diabetes care 2000;23(9):1310-5.
2000: M Iida; Masahiro Ikeda; M Kishimoto; T Tsujino; Hideaki Kaneto; Munehide Matsuhisa; Yoshitaka Kajimoto; Takao Watarai; Yoshimitsu Yamasaki; Masatsugu Hori
Evaluation of gut motility in type II diabetes by the radiopaque marker method.
Journal of gastroenterology and hepatology 2000;15(4):381-5.
2000: M Kodama; Yoshimitsu Yamasaki; Ken'ya Sakamoto; R Yoshioka; Munehide Matsuhisa; Yoshitaka Kajimoto; Keisuke Kosugi; N Ueda; Masatsugu Hori
Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.
Thrombosis research 2000;97(4):239-45.
2000: Eiichi Imano; R Yoshioka; Y Nakatani; K Arai; M Motomura; Tsutomu Kanda; Yoshimitsu Yamasaki; Masatsugu Hori
QT dispersion is increased in diabetic patients with foot ulcer.
Journal of atherosclerosis and thrombosis 2000;6(1):13-7.
2000: Munehide Matsuhisa; Yoshimitsu Yamasaki; Yuichi Shiba; Itsuro Nakahara; Akio Kuroda; T Tomita; M Iida; Masahiro Ikeda; Yoshitaka Kajimoto; Minoru Kubota; Masatsugu Hori
Important role of the hepatic vagus nerve in glucose uptake and production by the liver.
Metabolism: clinical and experimental 2000;49(1):11-6.
1999: Yoshitaka Kajimoto; T a Matsuoka; Hideaki Kaneto; Hirotaka Watada; Yoshio Fujitani; M Kishimoto; Ken'ya Sakamoto; Munehide Matsuhisa; R Kawamori; Yoshimitsu Yamasaki; Masatsugu Hori
Induction of glycation suppresses glucokinase gene expression in HIT-T15 cells.
Diabetologia 1999;42(12):1417-24.
1999: M Yamamoto; Yoshimitsu Yamasaki; M Kodama; Munehide Matsuhisa; M Kishimoto; H Ozaki; A Tani; N Ueda; M Iwasaki; Masatsugu Hori
Impaired diurnal cardiac autonomic function in subjects with type 2 diabetes.
Diabetes care 1999;22(12):2072-7.
1999: Hideaki Kaneto; Yoshitaka Kajimoto; Jun-ichiro Miyagawa; T a Matsuoka; Yoshio Fujitani; Yutaka Umayahara; Toshiaki Hanafusa; Yuji Matsuzawa; Yoshimitsu Yamasaki; Masatsugu Hori
Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.
Diabetes 1999;48(12):2398-406.
1999: Yoshio Fujitani; Yoshitaka Kajimoto; Tetsuyuki Yasuda; T a Matsuoka; Hideaki Kaneto; Yutaka Umayahara; N Fujita; Hirotaka Watada; J i Miyazaki; Yoshimitsu Yamasaki; Masatsugu Hori
Identification of a portable repression domain and an E1A-responsive activation domain in Pax4: a possible role of Pax4 as a transcriptional repressor in the pancreas.
Molecular and cellular biology 1999;19(12):8281-91.
1999: Takao Watarai; Yoshimitsu Yamasaki; Masahiro Ikeda; Minoru Kubota; M Kodama; T Tsujino; M Kishimoto; R Kawamori; Masatsugu Hori
Insulin resistance contributes to carotid arterial wall thickness in patients with non-insulin-dependent-diabetes mellitus.
Endocrine journal 1999;46(5):629-38.
1999: Eiichi Imano; Tsutomu Kanda; Y Nakatani; M Motomura; K Arai; Munehide Matsuhisa; Yoshimitsu Yamasaki; Masatsugu Hori
Impaired splanchnic and peripheral glucose uptake in liver cirrhosis.
Journal of hepatology 1999;31(3):469-73.
1999: Hideaki Kaneto; Yoshitaka Kajimoto; Yoshio Fujitani; T a Matsuoka; Ken'ya Sakamoto; Munehide Matsuhisa; Yoshimitsu Yamasaki; Masatsugu Hori
Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction.
Diabetologia 1999;42(9):1093-7.
1999: R Hamaoka; Junichi Fujii; Jun-ichiro Miyagawa; Masahiko Takahashi; M Kishimoto; Makoto Moriwaki; K Yamamoto; Yoshitaka Kajimoto; Yoshimitsu Yamasaki; Toshiaki Hanafusa; Yuji Matsuzawa; Naoyuki Taniguchi
Overexpression of the aldose reductase gene induces apoptosis in pancreatic beta-cells by causing a redox imbalance.
Journal of biochemistry 1999;126(1):41-7.
1998: Eiichi Imano; Tsutomu Kanda; Y Nakatani; Tsutomu Nishida; K Arai; M Motomura; Y Kajimoto; Yoshimitsu Yamasaki; Masatsugu Hori
Effect of troglitazone on microalbuminuria in patients with incipient diabetic nephropathy.
Diabetes care 1998;21(12):2135-9.
1998: Hideaki Kaneto; M Ikeda; M Kishimoto; M Iida; A Hoshi; Takao Watarai; M Kubota; Yoshitaka Kajimoto; Yoshimitsu Yamasaki; Masatsugu Hori
Dramatic recovery of counter-regulatory hormone response to hypoglycaemia after intensive insulin therapy in poorly controlled Type I diabetes mellitus.
Diabetologia 1998;41(8):982-3.
1998: Yuichi Shiba; Yoshimitsu Yamasaki; Minoru Kubota; Munehide Matsuhisa; T Tomita; Itsuro Nakahara; T Morishima; R Kawamori; Masatsugu Hori
Increased hepatic glucose production and decreased hepatic glucose uptake at the prediabetic phase in the Otsuka Long-Evans Tokushima fatty rat model.
Metabolism: clinical and experimental 1998;47(8):908-14.
1998: T Tomita; Yoshimitsu Yamasaki; Minoru Kubota; R Tohdo; M Katsura; Masahiro Ikeda; Itsuro Nakahara; Yuichi Shiba; Munehide Matsuhisa; Masatsugu Hori
High plasma free fatty acids decrease splanchnic glucose uptake in patients with non-insulin-dependent diabetes mellitus.
Endocrine journal 1998;45(2):165-73.
1998: Yoshimitsu Yamasaki
[Drug delivery system for diabetes].
Nihon rinsho. Japanese journal of clinical medicine 1998;56(3):748-51.
1998: Eiichi Imano; Tsutomu Kanda; Y Ishigami; M Kubota; M Ikeda; Munehide Matsuhisa; R Kawamori; Yoshimitsu Yamasaki
Interferon induces insulin resistance in patients with chronic active hepatitis C.
Journal of hepatology 1998;28(2):189-93.
1998: Yoshimitsu Yamasaki; Takao Watarai; M Kodama
[Carotid wall thickness].
Nihon rinsho. Japanese journal of clinical medicine 1998;56 Suppl 3():479-83.
1998: Munehide Matsuhisa; H Nishizawa; Masahiro Ikeda; Minoru Kubota; S Arai; R Kawamori; Yoshimitsu Yamasaki
Prior muscular contraction enhances disposal of glucose analog in the liver and muscle.
Metabolism: clinical and experimental 1998;47(1):44-9.
1997: K Arai; Yoshimitsu Yamasaki; Yoshitaka Kajimoto; Hirotaka Watada; Yutaka Umayahara; M Kodama; Ken'ya Sakamoto; Masatsugu Hori
Association of methylenetetrahydrofolate reductase gene polymorphism with carotid arterial wall thickening and myocardial infarction risk in NIDDM.
Diabetes 1997;46(12):2102-4.
1997: Hideaki Kaneto; Jun-ichiro Miyagawa; Yoshitaka Kajimoto; Koji Yamamoto; Hirotaka Watada; Yutaka Umayahara; Toshiaki Hanafusa; Yuji Matsuzawa; Yoshimitsu Yamasaki; Shigeki Higashiyama; Naoyuki Taniguchi
Expression of heparin-binding epidermal growth factor-like growth factor during pancreas development. A potential role of PDX-1 in transcriptional activation.
The Journal of biological chemistry 1997;272(46):29137-43.
1997: Yoshimitsu Yamasaki; R Kawamori; T Wasada; A Sato; Y Omori; H Eguchi; M Tominaga; H Sasaki; Masahiro Ikeda; Minoru Kubota; Y Ishida; T Hozumi; S Baba; M Uehara; M Shichiri; T Kaneko
Pioglitazone (AD-4833) ameliorates insulin resistance in patients with NIDDM. AD-4833 Glucose Clamp Study Group, Japan.
The Tohoku journal of experimental medicine 1997;183(3):173-83.
1997: Hideaki Kaneto; Yoshimitsu Yamasaki
[Diabetes and apoptosis].
Nihon rinsho. Japanese journal of clinical medicine 1997;55 Suppl():755-8.
1997: Yoshitaka Kajimoto; Hirotaka Watada; T a Matsuoka; Hideaki Kaneto; Yoshio Fujitani; Jun-ichi Miyazaki; Yoshimitsu Yamasaki
Suppression of transcription factor PDX-1/IPF1/STF-1/IDX-1 causes no decrease in insulin mRNA in MIN6 cells.
The Journal of clinical investigation 1997;100(7):1840-6.
1997: M Waguri; Kazuhiro Yamamoto; Jun-ichiro Miyagawa; Yoshihiro Tochino; Katsumi Yamamori; Yoshitaka Kajimoto; Hiromu Nakajima; Hirotaka Watada; Issei Yoshiuchi; N Itoh; Akihisa Imagawa; Mitsuyoshi Namba; Masamichi Kuwajima; Yoshimitsu Yamasaki; Toshiaki Hanafusa; Yuji Matsuzawa
Demonstration of two different processes of beta-cell regeneration in a new diabetic mouse model induced by selective perfusion of alloxan.
Diabetes 1997;46(8):1281-90.
1997: Munehide Matsuhisa; T Morishima; Itsuro Nakahara; T Tomita; Yuichi Shiba; Minoru Kubota; M Wada; Tsutomu Kanda; M Kubota; R Kawamori; Yoshimitsu Yamasaki
Augmentation of hepatic glucose uptake by a positive glucose gradient between hepatoportal and central nervous systems.
Diabetes 1997;46(7):1101-5.
1997: M Kishimoto; Yoshitaka Kajimoto; Minoru Kubota; Takao Watarai; Y Shiba; R Kawamori; T Inaba; T Kamada; Yoshimitsu Yamasaki
Sensitive, selective gas chromatographic-mass spectrometric analysis with trifluoroacetyl derivatives and a stable isotope for studying tissue sorbitol-producing activity.
Journal of chromatography. B, Biomedical sciences and applications 1997;688(1):1-10.
1997: K Arai; Yoshitaka Kajimoto; Yoshimitsu Yamasaki
Rarity of the Asn291Ser mutation of lipoprotein lipase gene in Japanese NIDDM patients.
Diabetes research and clinical practice 1997;34(3):181-2.
1997: T a Matsuoka; Yoshitaka Kajimoto; Hirotaka Watada; Hideaki Kaneto; M Kishimoto; Yutaka Umayahara; Yoshio Fujitani; T Kamada; R Kawamori; Yoshimitsu Yamasaki
Glycation-dependent, reactive oxygen species-mediated suppression of the insulin gene promoter activity in HIT cells.
The Journal of clinical investigation 1997;99(1):144-50.
1996: Hirotaka Watada; Yoshitaka Kajimoto; Hideaki Kaneto; T Matsuoka; Yoshio Fujitani; J i Miyazaki; Yoshimitsu Yamasaki
Involvement of the homeodomain-containing transcription factor PDX-1 in islet amyloid polypeptide gene transcription.
Biochemical and biophysical research communications 1996;229(3):746-51.
1996: Hideaki Kaneto; Junichi Fujii; T Myint; Nobuko Miyazawa; K N Islam; Y Kawasaki; Keiichiro Suzuki; M Nakamura; H Tatsumi; Yoshimitsu Yamasaki; Naoyuki Taniguchi
Reducing sugars trigger oxidative modification and apoptosis in pancreatic beta-cells by provoking oxidative stress through the glycation reaction.
The Biochemical journal 1996;320 ( Pt 3)():855-63.
1996: Hirotaka Watada; Yoshitaka Kajimoto; Jun-ichiro Miyagawa; Toshiaki Hanafusa; K Hamaguchi; T Matsuoka; K Yamamoto; Yuji Matsuzawa; R Kawamori; Yoshimitsu Yamasaki
PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin.
Diabetes 1996;45(12):1826-31.
1996: Hirotaka Watada; Yoshitaka Kajimoto; Yutaka Umayahara; T Matsuoka; Hideaki Kaneto; Yoshio Fujitani; T Kamada; R Kawamori; Yoshimitsu Yamasaki
The human glucokinase gene beta-cell-type promoter: an essential role of insulin promoter factor 1/PDX-1 in its activation in HIT-T15 cells.
Diabetes 1996;45(11):1478-88.
1996: Yoshimitsu Yamasaki; M Kodama
[Atherosclerosis in subjects with mild hyperglycemia].
Nihon rinsho. Japanese journal of clinical medicine 1996;54(10):2700-3.
1996: A Hoshi; M Takahashi; Junichi Fujii; T Myint; Hideaki Kaneto; Keiichiro Suzuki; Yoshimitsu Yamasaki; T Kamada; Naoyuki Taniguchi
Glycation and inactivation of sorbitol dehydrogenase in normal and diabetic rats.
The Biochemical journal 1996;318 ( Pt 1)():119-23.
1996: Yoshitaka Kajimoto; Jun-ichiro Miyagawa; K Ishihara; Y Okuyama; Yoshio Fujitani; M Itoh; H Yoshida; Tsuneyasu Kaisho; T Matsuoka; Hirotaka Watada; Toshiaki Hanafusa; Yoshimitsu Yamasaki; T Kamada; Yuji Matsuzawa; Toshio Hirano
Pancreatic islet cells express BST-1, a CD38-like surface molecule having ADP-ribosyl cyclase activity.
Biochemical and biophysical research communications 1996;219(3):941-6.
1996: Minoru Kubota; Yoshimitsu Yamasaki; M Sekiya; M Kubota; T Morishima; M Kishimoto; R Kawamori; M Shichiri; T Kamada
Portal insulin delivery is superior to peripheral delivery in handling of portally delivered glucose.
Metabolism: clinical and experimental 1996;45(2):150-4.
1995: T Matsuoka; Yoshitaka Kajimoto; Hirotaka Watada; Yutaka Umayahara; M Kubota; R Kawamori; Yoshimitsu Yamasaki; T Kamada
Expression of CD38 gene, but not of mitochondrial glycerol-3-phosphate dehydrogenase gene, is impaired in pancreatic islets of GK rats.
Biochemical and biophysical research communications 1995;214(1):239-46.
1995: M Kishimoto; Yoshimitsu Yamasaki; Minoru Kubota; K Arai; T Morishima; R Kawamori; T Kamada
1,5-Anhydro-D-glucitol evaluates daily glycemic excursions in well-controlled NIDDM.
Diabetes care 1995;18(8):1156-9.
1995: M Sekiya; Yoshimitsu Yamasaki; T Tsujino; Yuichi Shiba; Minoru Kubota; R Kawamori; T Kamada
Insulin resistance in essential hypertensive patients with impaired glucose tolerance.
Diabetes research and clinical practice 1995;29(1):49-56.
1995: Hideaki Kaneto; Junichi Fujii; H G Seo; Keiichiro Suzuki; T Matsuoka; M Nakamura; H Tatsumi; Yoshimitsu Yamasaki; T Kamada; Naoyuki Taniguchi
Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells.
Diabetes 1995;44(7):733-8.
1995: Yoshimitsu Yamasaki; R Kawamori; H Matsushima; H Nishizawa; M Kodama; Minoru Kubota; Yoshitaka Kajimoto; T Kamada
Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery.
Diabetologia 1995;38(5):585-91.
1995: R Kawamori; M Katsura; S Ishida; Yoshimitsu Yamasaki; M Tujii; Sunao Kawano; T Kamada
Subclinical exocrine pancreatic derangement in human diabetic patients evaluated from pure pancreatic juice.
Journal of diabetes and its complications 1995;9(2):69-73.
1995: Hirotaka Watada; Yoshitaka Kajimoto; Yutaka Umayahara; T Matsuoka; T Morishima; Yoshimitsu Yamasaki; R Kawamori; T Kamada
Ubiquitous, but variable, expression of two alternatively spliced mRNAs encoding mouse homologues of transcription factors E47 and E12.
Gene 1995;153(2):255-9.
1995: Yoshitaka Kajimoto; R Kawamori; Y Fujitani; M Kishimoto; Minoru Kubota; Yoshimitsu Yamasaki; T Morishima; T Kamada
A case of non-insulin dependent diabetes mellitus with antiinsulin antibody: effect of subcutaneous injection of human recombinant insulin-like growth factor-I.
Endocrine journal 1995;42(1):101-5.
1994: Yoshimitsu Yamasaki; Yuichi Shiba; M Sekiya; T Tsujino; N Hakui; R Kawamori; T Kamada
Selective alpha 1-adrenergic inhibition improves decrease glucose disposal in patients with essential hypertension.
Journal of human hypertension 1994;8(8):555-8.
1994: Yutaka Umayahara; R Kawamori; Hirotaka Watada; Eiichi Imano; N Iwama; T Morishima; Yoshimitsu Yamasaki; Yoshitaka Kajimoto; T Kamada
Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer.
The Journal of biological chemistry 1994;269(23):16433-42.
1994: R Kawamori; Eiichi Imano; Takao Watarai; H Nishizawa; H Matsushima; M Kodama; Yoshimitsu Yamasaki; T Kamada
Platelet activation in diabetic patients with asymptomatic atherosclerosis.
Diabetes research and clinical practice 1994;24(2):89-95.
1994: Yoshimitsu Yamasaki; R Kawamori; H Matsushima; H Nishizawa; M Kodama; Yoshitaka Kajimoto; T Morishima; T Kamada
Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging.
Diabetes 1994;43(5):634-9.
1994: Yoshitaka Kajimoto; R Kawamori; Yutaka Umayahara; Hirotaka Watada; N Iwama; T Morishima; Yoshimitsu Yamasaki; T Kamada
Identification of amino-acid polymorphism within the leucine zipper motif of mouse transcription factor A1.
Gene 1994;139(2):247-9.
1993: M Katsura; R Kawamori; Yoshimitsu Yamasaki; N Iwama; Minoru Kubota; Y Goriya; Yoshitaka Kajimoto; M Shichiri; T Kamada
Improvement in blunted glucagon response to insulin-induced hypoglycemia by strict glycemic control in diabetics.
Diabetes research and clinical practice 1993;20(2):93-100.
1993: Eiichi Imano; R Kawamori; N Iwama; Yutaka Umayahara; Yoshimitsu Yamasaki; T Kamada
Rapid screening method of abnormal insulin-receptor gene expression: allele-specific oligonucleotide hybridization by using silent polymorphisms.
Biochimica et biophysica acta 1993;1181(2):131-4.
1993: M Kishimoto; R Kawamori; Minoru Kubota; Masahiro Ikeda; T Morishima; Yoshimitsu Yamasaki; T Kamada
Clinical usefulness of a non-wiping type glucose meter in diabetic patients.
Diabetes research and clinical practice 1993;20(1):47-50.
1993: Yoshitaka Kajimoto; R Kawamori; Yutaka Umayahara; N Iwama; Eiichi Imano; T Morishima; Yoshimitsu Yamasaki; T Kamada
An AP-1 enhancer mediates TPA-induced transcriptional activation of the chicken insulin-like growth factor I gene.
Biochemical and biophysical research communications 1993;190(3):767-73.
1992: R Kawamori; Yoshimitsu Yamasaki; H Matsushima; H Nishizawa; K Nao; Hidetaka Hougaku; H Maeda; N Handa; M Matsumoto; T Kamada
Prevalence of carotid atherosclerosis in diabetic patients. Ultrasound high-resolution B-mode imaging on carotid arteries.
Diabetes care 1992;15(10):1290-4.
1992: Yoshimitsu Yamasaki; R Kawamori; K Bando; M Katsura; N Iwama; Minoru Kubota; M Shichiri; T Kamada
Normoglycemia per se but not normoinsulinemia is responsible for suppressing endogenous insulin secretion after oral glucose load in NIDDM.
Diabetes research and clinical practice 1992;15(2):113-9.
1991: J Y Lee; N Iwama; Takao Watarai; Yoshimitsu Yamasaki; R Kawamori; T Kamada
Inhibitory effect of methylguanidine on insulin binding to its receptor. Mechanism underlying insulin resistance in uremia.
Diabetes research and clinical practice 1991;13(3):173-80.
1991: Yoshimitsu Yamasaki; N Ueda; M Kishimoto; A Tani; Y Ishida; R Kawamori; T Kamada
Assessment of early stage autonomic nerve dysfunction in diabetic subjects--application of power spectral analysis of heart rate variability.
Diabetes research (Edinburgh, Scotland) 1991;17(2):73-80.
1991: N Iwama; Takao Watarai; Yoshitaka Kajimoto; Yoshimitsu Yamasaki; T Yokoyama; R Kawamori; T Kamada
Dephosphorylation of the insulin receptor partially restores the decreased autophosphorylation in streptozotocin induced diabetic rats.
Diabetes research (Edinburgh, Scotland) 1991;17(1):25-32.
1989: N Iwama; Y Saito; M Nomura; Eiichi Imano; Takao Watarai; Yoshimitsu Yamasaki; R Kawamori; T Kamada
5'-flanking DNA of the human insulin receptor gene and long terminal repeat of mouse mammary tumour virus bind to the same nuclear protein(s).
Diabetologia 1989;32(12):877-80.
1989: R Kawamori; K Bando; Yoshimitsu Yamasaki; Minoru Kubota; Takao Watarai; N Iwama; M Shichiri; T Kamada
Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
Diabetes care 1989;12(10):680-5.
1989: Yoshimitsu Yamasaki; N Ueda; K Nao; M Sekiya; R Kawamori; M Shichiri; T Kamada
Direct measurement of whole blood glucose by a needle-type sensor.
Clinica chimica acta; international journal of clinical chemistry 1989;180(1):93-8.
1989: Yoshimitsu Yamasaki; R Kawamori; R Tohdo; M Nomura; Minoru Kubota; T Kamada; M Shichiri
Simultaneous evaluation of insulin secretion and action using a model.
Diabetes research and clinical practice 1989;6(1):17-25.
1988: Y Goriya; N Ueda; K Nao; Yoshimitsu Yamasaki; R Kawamori; M Shichiri; T Kamada
Fail-safe systems for the wearable artificial endocrine pancreas.
The International journal of artificial organs 1988;11(6):482-6.
1988: T Yagi; Yoshimitsu Yamasaki; K Bando; R Kawamori; T Kamada; M Shichiri
The evaluation of glucagon infusion algorithms for a counterregulatory system in artificial endocrine pancreas.
Medical progress through technology 1988;13(4):195-201.
1987: N Asakawa; Y Saito; Yoshimitsu Yamasaki; R Kawamori; M Shichiri
Validation of closed-loop subcutaneous insulin infusion algorithm--application of subcutaneous insulin absorption kinetics.
Diabetes research (Edinburgh, Scotland) 1987;5(4):193-8.
1985: M Shichiri; R Kawamori; Y Goriya; Yoshimitsu Yamasaki; M Nomura; N Asakawa; Minoru Kubota; T Kamada
Long-term application of wearable artificial endocrine pancreas--closed-loop intravenous vs subcutaneous insulin infusion.
Life support systems : the journal of the European Society for Artificial Organs 1985;3 Suppl 1():583-7.
1984: M Shichiri; R Kawamori; N Hakui; Yoshimitsu Yamasaki; H Abe
Closed-loop glycemic control with a wearable artificial endocrine pancreas. Variations in daily insulin requirements to glycemic response.
Diabetes 1984;33(12):1200-2.
1984: M Shichiri; R Kawamori; N Hakui; N Asakawa; Yoshimitsu Yamasaki; H Abe
The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
Biomedica biochimica acta 1984;43(5):561-8.
1983: M Shichiri; R Kawamori; Y Goriya; Yoshimitsu Yamasaki; M Nomura; N Hakui; H Abe
Glycaemic control in pancreatectomized dogs with a wearable artificial endocrine pancreas.
Diabetologia 1983;24(3):179-84.
1983: T Yagi; N Hakui; Yoshimitsu Yamasaki; R Kawamori; M Shichiri; H Abe; S Kim; M Miyake; K Kamikawa; T Nishihata; A Kamada
Insulin suppository: enhanced rectal absorption of insulin using an enamine derivative as a new promoter.
The Journal of pharmacy and pharmacology 1983;35(3):177-8.
1982: M Shichiri; R Kawamori; Yoshimitsu Yamasaki; N Hakui; H Abe
Wearable artificial endocrine pancrease with needle-type glucose sensor.
Lancet 1982;2(8308):1129-31.
1981: Yoshimitsu Yamasaki; M Shichiri; R Kawamori; M Kikuchi; T Yagi; S Arai; R Tohdo; N Hakui; N Oji; H Abe
The effectiveness of rectal administration of insulin suppository on normal and diabetic subjects.
Diabetes care 1981;4(4):454-8.
1981: Yoshimitsu Yamasaki; M Shichiri; R Kawamori; T Morishima; N Hakui; T Yagi; H Abe
The effect of rectal administration of insulin on the short-term treatment of alloxan-diabetic dogs.
Canadian journal of physiology and pharmacology 1981;59(1):1-6.